Boxlight Corp (BOXL): Nasdaq/NYSE listing notice — Boxlight receives Nasdaq delisting notice for bid price non-compliance; 180-day cure period until Aug 26, 2024

Boxlight Corp

Nasdaq notified Boxlight on Feb 28, 2024 that closing bid price was below $1 for 30 consecutive business days.
Company has 180 days (until Aug 26, 2024) to regain compliance by having bid price at least $1 for 10 consecutive days.
If not compliant by Aug 26, Boxlight may seek a second 180-day period by meeting other listing standards and intending to cure via reverse stock split.
Boxlight's common stock continues to trade on Nasdaq during the compliance period.
Company is evaluating options including a potential reverse stock split to cure the deficiency.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Boxlight Corp received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

February 28, 2024, Boxlight Corporation (the “Company”), received a letter from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that based upon the closing bid price for the last 30 consecutive business days, the Company no longer meets the Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”). The notification received has no immediate effect on the Company’s Nasdaq listing. In accordance with Nasdaq Listing Rule 5810(c)(3)(A) (the “Compliance Period Rule”), the Company has been provided an initial period of 180 calendar days, or

View on SEC.gov

Browse all listing & compliance notices →

Boxlight Corp filing history →

Source: SEC EDGAR

accession 0001104659-24-030543

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.